[Comparative evaluation of the vasodilator effect of kurantil and no-spa in population and twin studies].
Based on the results of acute clinical and pharmacological tests with 10 mg curantyl and 40 mg no-spa in 55 patients with coronary heart disease (CHD) and 14 pairs of monozygote twins curantyl was discovered to make the central and peripheral hemodynamics return to normal during CHD. The vasodilative effects of curantyl and no-spa on the skeletal muscles were not basically different in the population groups indicated.
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy / Q000503:physiopathology; D001775:Blood Circulation / Q000187:drug effects; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy / Q000503:physiopathology; D004176:Dipyridamole / Q000627:therapeutic use*; D004200:Diseases in Twins; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011247:Pregnancy; D013997:Time Factors; D014430:Twins, Monozygotic; D014665:Vasodilator Agents / Q000627:therapeutic use*
D014665:Vasodilator Agents; D004176:Dipyridamole; C005317:drotaverin; D010208:Papaverine
K sravnitel'noĭ ostenke sosudorasshiriaiushchego éffekta kurantila i no-shpy v populiatsionnykh i bliznetsovykh issledovaniiakh.